Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Filpula

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biomolecular Engineering|May 1, 2007
Antibody engineering and modification technologiesDavid Filpula
Advanced Drug Delivery Reviews|September 22, 2007
Releasable PEGylation of proteins with customized linkersDavid Filpula, Hong Zhao
Bioconjugate Chemistry|March 20, 2003
Controlled release of proteins from their poly(ethylene glycol) conjugates: drug delivery systems employing 1,6-eliminationRichard B Greenwald, Karen Yang, Hong Zhao, et al.
Bioconjugate Chemistry|March 16, 2006
Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteinsHong Zhao, Karen Yang, Anthony Martinez, et al.
Molecular Cancer Therapeutics|November 1, 2008
A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growthLee M Greenberger, Ivan D Horak, David Filpula, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 8, 2005
Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivoDeshan Yu, Ping Peng, Sonia S Dharap, et al.
Protein Engineering|November 6, 2003
Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylationKaren Yang, Amartya Basu, Maoliang Wang, et al.
Bioconjugate Chemistry|November 16, 2006
Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidisMaoliang Wang, Amartya Basu, Thomas Palm, et al.
Bioconjugate Chemistry|May 18, 2006
Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylationAmartya Basu, Karen Yang, Maoliang Wang, et al.
Bioconjugate Chemistry|March 10, 2007
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in miceDavid Filpula, Karen Yang, Amartya Basu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biomolecular Engineering|May 1, 2007
Antibody engineering and modification technologiesDavid Filpula
Advanced Drug Delivery Reviews|September 22, 2007
Releasable PEGylation of proteins with customized linkersDavid Filpula, Hong Zhao
Bioconjugate Chemistry|March 20, 2003
Controlled release of proteins from their poly(ethylene glycol) conjugates: drug delivery systems employing 1,6-eliminationRichard B Greenwald, Karen Yang, Hong Zhao, et al.
Bioconjugate Chemistry|March 16, 2006
Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteinsHong Zhao, Karen Yang, Anthony Martinez, et al.
Molecular Cancer Therapeutics|November 1, 2008
A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growthLee M Greenberger, Ivan D Horak, David Filpula, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 8, 2005
Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivoDeshan Yu, Ping Peng, Sonia S Dharap, et al.
Protein Engineering|November 6, 2003
Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylationKaren Yang, Amartya Basu, Maoliang Wang, et al.
Bioconjugate Chemistry|November 16, 2006
Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidisMaoliang Wang, Amartya Basu, Thomas Palm, et al.
Bioconjugate Chemistry|May 18, 2006
Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylationAmartya Basu, Karen Yang, Maoliang Wang, et al.
Bioconjugate Chemistry|March 10, 2007
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in miceDavid Filpula, Karen Yang, Amartya Basu, et al.
Pageof 2